Kalpataru Projects shares have risen 3% as the subsidiary secures Rs 2,349-crore orders, showcasing strong performance.
Read MoreSymbiotec Pharmalab EIR: A Clear Win for Investors
Symbiotec Pharmalab EIR news highlights the positive FDA approval impact on the company.
Read More
